Histone deacetylase inhibition: a new target for Peyronie's disease?

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-410x|114|6|796-796

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.114, Iss.6, 2014-12, pp. : 796-796

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Silencing histone deacetylase 2 using small hairpin RNA induces regression of fibrotic plaque in a rat model of Peyronie's disease

By  

BJU INTERNATIONAL, Vol. 114, Iss. 6, 2014-12 ,pp. : 926-936

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genome-Wide STAT3 Binding Analysis after Histone Deacetylase Inhibition Reveals Novel Target Genes in Dendritic Cells

By  

Journal of Innate Immunity, Vol. 9, Iss. 2, 2016-11 ,pp. : 126-144

Karger

Access to resources Recommend Favorite

Validation of histone deacetylase 3 as a therapeutic target in castration‐resistant prostate cancer

By  

THE PROSTATE, Vol. 78, Iss. 4, 2018-03 ,pp. : 266-277

John Wiley & Sons Inc

Access to resources Recommend Favorite

PEYRONIE'S DISEASE

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 19, Iss. 11, 1971-11 ,pp. : 947-955

John Wiley & Sons Inc

Access to resources Recommend Favorite

The histone deacetylase sirtuin 2 is a new player in the regulation of platelet function

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 7, 2015-07 ,pp. : 1335-1344

John Wiley & Sons Inc

Access to resources Recommend Favorite